BioMérieux and NuGen Ink Cross-License Agreement for Amplification Technologies | GenomeWeb
This article has been updated from a previous version, which incorrectly stated that BioMérieux acquired exclusive rights to NuGen's amplification system. 
NEW YORK (GenomeWeb News) - BioMérieux and NuGen Technologies have signed a cross-license and supply agreement to share amplification technologies for expression analysis, the companies said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.